Oncology Pharma (OTCMKTS:ONPH) Stock Price Down 3.6%

Oncology Pharma Inc. (OTCMKTS:ONPHGet Rating) shares traded down 3.6% during mid-day trading on Monday . The company traded as low as $1.33 and last traded at $1.35. 83,552 shares changed hands during trading, a decline of 18% from the average session volume of 101,986 shares. The stock had previously closed at $1.40.

Oncology Pharma Trading Down 3.6 %

The stock has a 50-day moving average price of $1.65 and a 200-day moving average price of $3.06.

Oncology Pharma Company Profile

(Get Rating)

Oncology Pharma Inc, an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc and changed its name to Oncology Pharma Inc in June 2019.

Featured Articles

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.